Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing

Couturaud Francis

Source: Eur Respir J 2016; 47:1313-1314
Journal Issue: May
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Couturaud Francis. Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing. Eur Respir J 2016; 47:1313-1314

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE)
Source: Eur Respir J 2003; 22: Suppl. 45, 220s
Year: 2003

The changing of D-dimer in the thrombolytic process of pulmonary thromboembolism
Source: Eur Respir J 2006; 28: Suppl. 50, 401s
Year: 2006

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016



Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016


Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism
Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018
Year: 2018



Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19?
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021


Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017
Year: 2018



D-dimer testing and pre-test probability scoring in the diagnosis of venous thromboembolism
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

Direct oral anticoagulants and venous thromboembolism
Source: Eur Respir Rev 2016; 25: 295-302
Year: 2016



Efficiency of r-TPA therapy in major venous thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 83s
Year: 2007

D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia
Source: Eur Respir J 2006; 28: Suppl. 50, 46s
Year: 2006

Venous thrombo-embolism prophylaxis
Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach
Year: 2009


The prevalence of hyperhomocysteinemia in venous thromboembolism
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006

Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021
Year: 2022



Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
Source: Eur Respir Rev, 27 (150) 180094; 10.1183/16000617.0094-2018
Year: 2018



Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007

Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Therapeutic aspects of pulmonary embolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=25
Year: 2004

Incidental venous thromboembolism, detected by chance, but still venous thromboembolism
Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020
Year: 2020



Treatment and prevention of cancer-associated venous thromboembolism
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021